Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney

Abstract

Abstract: Objective To investigate the changes of the mRNA expressions of membrane type 3-matrix metalloproteinase (MT3-MMP) and tissue inhibitor of matrix metalloproteinase 2 (TIMP2) in diabetic rat kidneys and the effect of losartan on such changes. Methods Three groups of male Wistar rats were used in this study, namely group A as the control group (n=11), group B consisting of diabetic rats without any therapy (n=11), and group C treated with losartan (n=9). Six months after treatment, the kidneys were taken from the rats to measure the mRNA expressions of MT3-MMP, TIMP2 and transforming growth factor β1(TGFβ1)with reverse transcriptional PCR (RT-PCR), and observe the glomerular basement membrane thickening and mesangial matrix(MM)density (MM area/mesangial area) with electron microscope. Twenty-four-hour urine was also collected to measure urinary albumin excretion (UAE). Results The expression of renal MT3-MMP mRNA in group B (1.37±0.96) was significantly stronger than those in group A (0.75±0.34, P<0.05) and in group C (0.75±0.30, P<0.05). The mRNA expression of renal TIMP2 in group B (0.73±0.37) was significantly increased as compared with group A (0.32±0.19, P<0.05) and group C (0.34±0.17, P<0.05), with a higher mRNA expression of renal TGFβ1 in grour B (0.53±0.20 vs 0.26±0.13 in group A and 0.29±0.15 in group C, P<0.05). UAE in group B (2.18±1.98mg) was significantly higher than those in groups A and C (0.41±0.47mg/d, P<0.05; 0.65±0.89 mg/d, P<0.05, respectively). The glomerular basement membrane thickness (532±108 nm) and the MM density (56.4±6.8) were significantly greater in group Bthan in the other two groups (P<0.05). Conclusions MT3-MMP and the TIMP2 mRNA expressions are significantly increased in diabetic rat kidneys. Losartan can prevent the development of diabetic nephropathy and inhibit MT3-MMP and the TIMP2 mRNA expressions in diabetic rat kidneys.

CLC Number:

R329.26

WAN Xia, HUANG Hu-hui, LI Jing-gao. Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney[J]. Journal of Southern Medical University, 2004, 24(12): 1391-1394.

References

[1] MecLenan SV, Fisher E J, Yue DK, et al. High glucose concentration causes a decrease in mesangium degradation[J]. Diabetes, 1994, 43(8): 1041-9.
[2] Davis M, Martin J, Thomas GJ, et al. Proteinase and glomerular matrix turnover[J]. Kidney Int, 1992, 41(3): 671-7.
[3] Brenner BM, Cooper ME, Zeeuw DD, et al. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J]. N Engl J Med, 2001, 345(12): 861-8.
[4] Lupia E, Elliot S J, Lenz O, et al. IGF1 decrease collagen degradation in diabetic NOD mesangial cells [J]. Diabetes, 1999, 48 (8):1638-42.
[5] Del Prete D, Angliani F, Forino M, et al. Down regulation of glomerular matrix metallo-proteinase-2 in human NIDDM [J]. Diabetologia, 1997, 40(12): 1449-52.
[6] Ueno H, Nakamura H, Inoue M, Imai K, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas [J]. Cancer Res, 1997, 15;57(10): 2055-260.
[7] Romanic AM, Burns-Kurtis CL, Ao Z, et al. Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients[J]. Am J Physiol Renal Physiol, 2001, 281(2): F309-17.
[8] Shankland S J, Ly H, Thai K, et al. Glomerular expression of tissue inhibitor of metalloproteinase(TIMP- 1) in normal diabetic rats [J]. J Am Soc Nephrol, 1996, 7(1): 97-81.
[9] MecLenan SV, Martell SY, Yue DK, et al. High glucose concentration inhibits the membrane metalloproteinase by mesangial cells:possible role in mesangial accumulation [J]. Diabetologia, 2000, 43(5): 642-6.
[10] Caenazzo C, Garbisa S, Onisto M, et al. Effects of glucose and heparin on mesangial alpha 1(Ⅳ ) collagen and MMP-2/TIMP-2 mRNA expression[J]. Nephrol Dial Transplant, 1997, 12(3): 443.
[11] Bariscosv WH, Cortez SL, Deboisblanc M, et al. Transforming growth factor-beta is a potent inhibitor of extracellular matrix degradation by cultured human mesangial cells [J]. J Am Soc Nephrol, 1999, 10(4): 790-5.
[12] Kagami S, Kuroda T, Okada K, et al. Dual effects of angiotensin on the plasminogen/plasmin system in rat mesangial cells [J]. Kidney Iht, 1997, 51(3): 664-9.
[13] Reckelhoff JF, Tygart VL, Racusen LC, et al. Glomerular metallproteinase activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP)[J]. Life Sci, 1994, 55: 941-50.
[14] Singh R, Song RH, Alavi N, et al. High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-betal [J]. Exp Nephrol, 2001, 9(4): 249-57.